UBS Group
RXO icon

UBS Group’s RXO RXO Stock Holding History

UBS Group’s Portfolio RXO Stock Details RXO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.1M Sell
909,106
-1,208,185
-57% -$26.7M ﹤0.01% 2442
2026
Q1 		$31M Buy
2,117,291
+597,641
+39% +$8.77M ﹤0.01% 2137
2025
Q4 		$19.2M Sell
1,519,650
-640,257
-30% -$9.44M ﹤0.01% 2624
2025
Q3 		$33.2M Buy
2,159,907
+679,040
+46% +$10.9M 0.01% 2035
2025
Q2 		$23.3M Buy
1,480,867
+414,961
+39% +$6.29M ﹤0.01% 2219
2025
Q1 		$20.4M Sell
1,065,906
-836,541
-44% -$18.3M ﹤0.01% 2301
2024
Q4 		$45.4M Buy
1,902,447
+1,759,105
+1,227% +$49.1M 0.01% 1551
2024
Q3 		$4.01M Sell
143,342
-29,936
-17% -$845K ﹤0.01% 3299
2024
Q2 		$4.53M Buy
173,278
+31,102
+22% +$647K ﹤0.01% 2968
2024
Q1 		$3.11M Buy
142,176
+1,647
+1% +$35.3K ﹤0.01% 3482
2023
Q4 		$3.27M Buy
140,529
+66,057
+89% +$1.33M ﹤0.01% 3255
2023
Q3 		$1.47M Sell
74,472
-77,443
-51% -$1.53M ﹤0.01% 3754
2023
Q2 		$3.44M Buy
151,915
+42,414
+39% +$854K ﹤0.01% 2971
2023
Q1 		$2.15M Sell
109,501
-305,811
-74% -$5.87M ﹤0.01% 3348
2022
Q4 		$7.14M Buy
+415,312
New +$7.37M ﹤0.01% 2169

Other funds holding RXO

OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
FC
Finepoint Capital Boston, Massachusetts $2.8B AUM 13.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

UBS Group's RXO Position: Q2 2026 in Review

UBS Group reduced its RXO (RXO) stake by 57% in Q2 2026, selling an estimated $26.7M and leaving 909,106 shares worth $25.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2442.

UBS Group first reported a position in RXO in Q4 2022 and has held it in 15 quarters since. The position peaked at $45.4M in Q4 2024. 304 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • UBS Group held 909,106 shares of RXO worth $25.1M as of Q2 2026.
  • UBS Group sold 1,208,185 RXO shares in Q2 2026, an estimated $26.7M.
  • RXO made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2442 holding.
  • UBS Group first reported a position in RXO in Q4 2022 and has held it in 15 quarters since.
  • UBS Group's RXO position peaked at $45.4M in Q4 2024.
  • 304 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.